The previous research has confirmed that IL-17 and Th17 enhance the proliferation, collagen synthesis and secretion, and migration of SSc patient-derived DVSMCs via the Mitogen-Activated Protein Kinase (MAPKs) signaling pathway.9 Here, WNK2 is linked to systemic sclerosis.